These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22190655)

  • 1. MR imaging of treated prostate cancer.
    Vargas HA; Wassberg C; Akin O; Hricak H
    Radiology; 2012 Jan; 262(1):26-42. PubMed ID: 22190655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging and MR spectroscopy in prostate cancer management.
    Katz S; Rosen M
    Radiol Clin North Am; 2006 Sep; 44(5):723-34, viii. PubMed ID: 17030223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
    Franiel T
    Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging of the prostate in clinical practice.
    Mazaheri Y; Shukla-Dave A; Muellner A; Hricak H
    MAGMA; 2008 Nov; 21(6):379-92. PubMed ID: 18795354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local staging of prostate cancer with MRI.
    Soylu FN; Eggener S; Oto A
    Diagn Interv Radiol; 2012; 18(4):365-73. PubMed ID: 22399364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of high-field MR in studies of localized prostate cancer.
    Lagemaat MW; Scheenen TW
    NMR Biomed; 2014 Jan; 27(1):67-79. PubMed ID: 23703839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MRI in follow-up after focal therapy for prostate carcinoma.
    De Visschere PJ; De Meerleer GO; Fütterer JJ; Villeirs GM
    AJR Am J Roentgenol; 2010 Jun; 194(6):1427-33. PubMed ID: 20489080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers.
    Fütterer JJ; Engelbrecht MR; Huisman HJ; Jager GJ; Hulsbergen-van De Kaa CA; Witjes JA; Barentsz JO
    Radiology; 2005 Nov; 237(2):541-9. PubMed ID: 16244263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
    Silverman JM; Krebs TL
    AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging in local staging of prostate cancer.
    Fütterer JJ
    Eur J Radiol; 2007 Sep; 63(3):328-34. PubMed ID: 17689908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging prostate cancer.
    Jung AJ; Westphalen AC
    Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging treated prostate cancer.
    De Visschere PJ; Vargas HA; Ost P; De Meerleer GO; Villeirs GM
    Abdom Imaging; 2013 Dec; 38(6):1431-46. PubMed ID: 23604966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of recurrent prostate cancer.
    Fütterer JJ
    Radiol Clin North Am; 2012 Nov; 50(6):1075-83. PubMed ID: 23122039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
    Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
    Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer.
    Patel P; Mathew MS; Trilisky I; Oto A
    Radiographics; 2018; 38(2):437-449. PubMed ID: 29373089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.